Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-066745
Filing Date
2025-07-23
Accepted
2025-07-22 17:45:50
Documents
13
Period of Report
2024-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0249924-8ka1_klotho.htm   iXBRL 8-K/A 31902
  Complete submission text file 0001213900-25-066745.txt   261126

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE klto-20240826.xsd EX-101.SCH 3496
3 XBRL DEFINITION FILE klto-20240826_def.xml EX-101.DEF 28591
4 XBRL LABEL FILE klto-20240826_lab.xml EX-101.LAB 38220
5 XBRL PRESENTATION FILE klto-20240826_pre.xml EX-101.PRE 26800
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0249924-8ka1_klotho_htm.xml XML 7396
Mailing Address 13576 WALNUT STREET, SUITE A OMAHA NE 68144
Business Address 13576 WALNUT STREET, SUITE A OMAHA NE 68144 (833) 931-6330
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41340 | Film No.: 251141228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)